Journals / JAREM / 2018 / Cilt: 8 - Sayı: 2

Therapeutic Plasma Exchange in Children with Neutropenic Sepsis: Single Center Experience

Nötropenik Sepsisli Çocuk Hastalarda Terapötik Plazma Değişimi: Tek Merkez Deneyimi

Journal
JAREM
Pages
59–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: TPE may be considered as an alternative treatment in children with neutropenic sepsis and multiple organ failure who do not respond to conventional sepsis treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The mortality rate is high for severe sepsis and septic shock.
📊
Key Findings & Data:Methods: For the present study, file records of three children with neutropenic sepsis who had undergone TPE between March 2015 and June 2016 were retrospectively reviewed.
💡
Conclusion & Impact:Conclusion: TPE may be considered as an alternative treatment in children with neutropenic sepsis and multiple organ failure who do not respond to conventional sepsis treatment.
🔬Design:Review & Systematic Survey
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The mortality rate is high for severe sepsis and septic shock. Presently, there are no specific treatments that can reduce mortality in patients with sepsis and multiple organ dysfunction. Therapeutic plasma exchange (TPE) is the automatic separation of a patient’s plasma using medical devices and its replacement with healthy donor plasma. TPE may be beneficial in selected cases, even though not routinely recommended by international sepsis guidelines. Methods: For the present study, file records of three children with neutropenic sepsis who had undergone TPE between March 2015 and June 2016 were retrospectively reviewed. Results: Two patients with acute leukemia, one patient with stage IV Burkitt lymphoma. All patients showed positive blood cultures. Candida krusei with Klebsiella pneumoniae was isolated in one patient, K. pneumoniae was isolated in the other patient, and C. krusei in the last patient. Multiple organ dysfunction developed in all patients and they showed no response to supportive therapy. Plasma exchange was performed 5, 1, and 13 times, respectively. After TPE, two patients fully recovered and one patient died due to natural course of the disease. None of the children developed complications associated with this procedure. Conclusion: TPE may be considered as an alternative treatment in children with neutropenic sepsis and multiple organ failure who do not respond to conventional sepsis treatment.

Özet

Amaç: Şiddetli sepsis ve septik şokta mortalite oranı yüksektir. Günümüzde sepsis ve çoklu organ yetmezliği olan hastalarda mortaliteyi azaltmak için spesifik bir tedavi şekli yoktur. Terapötik plazma değişimi, hastanın plazmasının medikal cihazlar ile otomatik olarak ayrılması ve bunun yerine sağlıklı donörlerden alınmış plazma verilmesidir. Her ne kadar uluslararası sepsis rehberleri tarafından rutin olarak önerilmese de seçilmiş olgularda terapötik plazma değişimi faydalı olabilir. Yöntemler: Çalışma için, Mart 2015 ve Haziran 2016 arasında terapötik plazma değişimi yapılan nötropenik sepsisli üç çocuk hastanın dosya bilgileri geriye dönük olarak incelendi. Bulgular: İki hasta akut lösemi, bir hasta evre IV Burkitt lenfoma idi. Tüm hastalarda kan kültürü pozitifti. Kan kültürlerinde, bir hastada Candida krusei ve Klebsiella pneumoniae, diğer hastada K. pneumoniae ve son hastada C. krusei izole edildi. Olguların hepsinde çoklu organ yetmezliği gelişti ve destek tedaviye yanıt alınamadı. Plazma değişimi sırası ile 5 kez, bir kez ve 13 kez yapıldı. İşlem sonrası iki hasta tamamen iyileşirken, bir hasta hastalığın doğal seyir nedeni ile kaybedildi. Hiçbir hastada işleme bağlı komplikasyon gelişmedi. Sonuç: Geleneksel sepsis tedavisine yanıt vermeyen, nötropenik sepsis ve çoklu organ yetmezliği olan çocuklarda terapötik plazma değişimi bir seçenek olarak düşünülebilir.

🔖

Cite This Article

ÖZDEMİR, Z. C., KAR, Y. D., BÖR, Ö. (2018). Therapeutic Plasma Exchange in Children with Neutropenic Sepsis: Single Center Experience. JAREM, Cilt: 8 - Sayı: 2, 59–62. https://ajindex.com/articles/192757

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Penack O, Becker C, Buchheidt D, Christopeit M, Kiehl M, von Lilienfeld-Toal M, et al. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol 2014; 93: 1083-95. [CrossRef] Jeddi R, Achour M, Amor RB, Aissaoui L, Bouterâa W, Kacem K, et al. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes. Hematology 2010; 15: 28-32. [CrossRef] Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, et al. Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Infect 2011; 62: 26-33. [CrossRef] Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A, et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43-9. [CrossRef] Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 2013; 31: 2810-8. [CrossRef] Kyles DM, Baltimore J. Adjunctive use of plasmepheresis and intravenous immunglobulin therapy in sepsis: a case report. Am J Crit Care 2005; 14: 109-12.
  2. Fortenberry JD, Paden ML. Extracorporeal therapies in the treatment of sepsis: experience and promise. Semin Pediatr Infect Dis 2006; 17: 72-9. [CrossRef] Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177. [CrossRef] Rimmer E, Houston BL, Kumar A, Abou-Setta AM, Friesen C, Marshall JC, et al. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: A systematic review and metaanalysis. Crit Care 2014; 18: 699. [CrossRef] Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic apheresisi in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28: 145-284. [CrossRef] Kawai Y, Cornell TT, Cooley EG, Beckman CN, Baldridge PK, Mottes TA, et al. Therapeutic plasma exchange may improve hemodyn